159 related articles for article (PubMed ID: 29383190)
1. Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.
Vollmar J; Lautem A; Closs E; Schuppan D; Kim YO; Grimm D; Marquardt JU; Fuchs P; Straub BK; Schad A; Gründemann D; Schattenberg JM; Gehrke N; Wörns MA; Baumgart J; Galle PR; Zimmermann T
Oncotarget; 2017 Dec; 8(70):115667-115680. PubMed ID: 29383190
[TBL] [Abstract][Full Text] [Related]
2. Functional inhibition of Oct leads to HNF4α upregulation.
Vollmar J; Kim YO; Marquardt JU; Galle PR; Schuppan D; Zimmermann T
Exp Ther Med; 2021 Apr; 21(4):349. PubMed ID: 33732322
[TBL] [Abstract][Full Text] [Related]
3. Deletion of organic cation transporter Oct3 promotes hepatic fibrosis via upregulation of TGFβ.
Vollmar J; Kim YO; Marquardt JU; Becker D; Galle PR; Schuppan D; Zimmermann T
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G195-G202. PubMed ID: 31241979
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
[TBL] [Abstract][Full Text] [Related]
6. Interaction of organic cation transporter 3 (SLC22A3) and amphetamine.
Zhu HJ; Appel DI; Gründemann D; Markowitz JS
J Neurochem; 2010 Jul; 114(1):142-9. PubMed ID: 20402963
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation.
Ahmadimoghaddam D; Zemankova L; Nachtigal P; Dolezelova E; Neumanova Z; Cerveny L; Ceckova M; Kacerovský M; Micuda S; Staud F
Biol Reprod; 2013 Mar; 88(3):55. PubMed ID: 23303678
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.
Schaeffeler E; Hellerbrand C; Nies AT; Winter S; Kruck S; Hofmann U; van der Kuip H; Zanger UM; Koepsell H; Schwab M
Genome Med; 2011 Dec; 3(12):82. PubMed ID: 22196450
[TBL] [Abstract][Full Text] [Related]
9. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.
Sala-Rabanal M; Li DC; Dake GR; Kurata HT; Inyushin M; Skatchkov SN; Nichols CG
Mol Pharm; 2013 Apr; 10(4):1450-8. PubMed ID: 23458604
[TBL] [Abstract][Full Text] [Related]
10. Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.
Solbach TF; Grube M; Fromm MF; Zolk O
J Cardiovasc Pharmacol; 2011 Oct; 58(4):409-17. PubMed ID: 21697722
[TBL] [Abstract][Full Text] [Related]
11. Organic cation transporter mRNA and function in the rat superior cervical ganglion.
Kristufek D; Rudorfer W; Pifl C; Huck S
J Physiol; 2002 Aug; 543(Pt 1):117-34. PubMed ID: 12181285
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.
Alim K; Moreau A; Bruyère A; Jouan E; Denizot C; Nies AT; Parmentier Y; Fardel O
Fundam Clin Pharmacol; 2021 Oct; 35(5):919-929. PubMed ID: 33523504
[TBL] [Abstract][Full Text] [Related]
15. Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat.
Ahmadimoghaddam D; Hofman J; Zemankova L; Nachtigal P; Dolezelova E; Cerveny L; Ceckova M; Micuda S; Staud F
Toxicol Sci; 2012 Aug; 128(2):471-81. PubMed ID: 22543277
[TBL] [Abstract][Full Text] [Related]
16. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.
Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
[TBL] [Abstract][Full Text] [Related]
17. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
[TBL] [Abstract][Full Text] [Related]
18. MPP
Mocking TAM; Sijben HJ; Vermeulen YW; IJzerman AP; Heitman LH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163125
[TBL] [Abstract][Full Text] [Related]
19. Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3.
Li DC; Nichols CG; Sala-Rabanal M
J Biol Chem; 2015 Nov; 290(46):27633-43. PubMed ID: 26405039
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of organic cation transporter 3 expressed in human placenta.
Sata R; Ohtani H; Tsujimoto M; Murakami H; Koyabu N; Nakamura T; Uchiumi T; Kuwano M; Nagata H; Tsukimori K; Nakano H; Sawada Y
J Pharmacol Exp Ther; 2005 Nov; 315(2):888-95. PubMed ID: 16081676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]